Symbols

USNA

Usana Health Sciences·NYSE

--(--)

7.82 / 10

Outperform

Analyst coverage is absent, but insider selling raises concern. Fund‑flow metrics are good (7.8/10) with small and medium investors net inflowing, while large and extra‑large investors show outflows, yielding a mixed capital sentiment.

Fund Flow Rating

What is the analyst consensus for USNA?

USNA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.82/10 (Outperform).